Masimo (MASI) EBT Growth (1y) (2010 - 2026)
Masimo (MASI) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.78% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 74.66% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 103.34% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -27.02% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 4.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 4.24% |
| Jan 3, 2026 | 192.73% |
| Sep 27, 2025 | 156.51% |
| Jun 28, 2025 | 79.87% |
| Mar 29, 2025 | 64.82% |
| Dec 28, 2024 | -266.25% |
| Sep 28, 2024 | 108.57% |
| Jun 29, 2024 | 24.19% |
| Mar 30, 2024 | 58.40% |
| Dec 30, 2023 | -13.82% |
| Sep 30, 2023 | -73.08% |
| Jul 1, 2023 | -6.77% |
| Apr 1, 2023 | -55.67% |
| Dec 31, 2022 | -28.00% |
| Oct 1, 2022 | -23.08% |
| Jul 2, 2022 | -59.20% |
| Apr 2, 2022 | -8.97% |
| Jan 1, 2022 | 57.13% |
| Oct 2, 2021 | 10.72% |
| Jul 3, 2021 | 2.48% |